Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $13173.9 billion.

  • Universe Pharmaceuticals' Total Current Liabilities fell 3514.52% to $13173.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13173.9 billion, marking a year-over-year decrease of 3514.52%. This contributed to the annual value of $13173.9 billion for FY2025, which is 3514.52% down from last year.
  • As of Q3 2025, Universe Pharmaceuticals' Total Current Liabilities stood at $13173.9 billion, which was down 3514.52% from $20313.0 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Total Current Liabilities peaked at $20313.0 billion during Q3 2024, and registered a low of $10.2 million during Q1 2022.
  • Moreover, its 5-year median value for Total Current Liabilities was $17.2 million (2023), whereas its average is $4185.9 billion.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 9999.99% in 2021, then surged by 14768408728.39% in 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Total Current Liabilities (Quarter) stood at $11.2 million in 2021, then grew by 16.83% to $13.1 million in 2022, then increased by 5.01% to $13.8 million in 2023, then surged by 147684087.28% to $20313.0 billion in 2024, then tumbled by 35.15% to $13173.9 billion in 2025.
  • Its last three reported values are $13173.9 billion in Q3 2025, $20313.0 billion for Q3 2024, and $20.6 million during Q1 2024.